CITIUS PHARMACEUTICALS INC's ticker is CTXR and the CUSIP is 17322U207. A total of 78 filers reported holding CITIUS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.07 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $721,539 | -41.5% | 1,054,265 | +2.5% | 0.00% | – |
Q2 2023 | $1,234,387 | +330.2% | 1,028,656 | +319.4% | 0.00% | – |
Q1 2023 | $286,932 | +52.5% | 245,241 | +2.9% | 0.00% | – |
Q4 2022 | $188,204 | -34.9% | 238,233 | 0.0% | 0.00% | – |
Q3 2022 | $289,000 | +31.4% | 238,233 | -0.2% | 0.00% | – |
Q2 2022 | $220,000 | -88.4% | 238,693 | -77.6% | 0.00% | – |
Q1 2022 | $1,904,000 | +23.7% | 1,063,417 | +6.4% | 0.00% | – |
Q4 2021 | $1,539,000 | -25.9% | 999,865 | -2.2% | 0.00% | – |
Q3 2021 | $2,076,000 | -54.1% | 1,022,548 | -21.3% | 0.00% | -100.0% |
Q2 2021 | $4,519,000 | +1041.2% | 1,298,509 | +484.3% | 0.00% | – |
Q1 2021 | $396,000 | +401.3% | 222,246 | +188.5% | 0.00% | – |
Q4 2020 | $79,000 | +79.5% | 77,026 | +83.9% | 0.00% | – |
Q3 2020 | $44,000 | +25.7% | 41,875 | +33.9% | 0.00% | – |
Q2 2020 | $35,000 | +250.0% | 31,267 | +84.5% | 0.00% | – |
Q1 2020 | $10,000 | – | 16,947 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Avenue Asset Management, LP | 84,878 | $120,000 | 0.01% |
DIMENSIONAL FUND ADVISORS LP | 13,938 | $20,000 | 0.00% |
WELLS FARGO & COMPANY/MN | 2,000 | $3,000 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
MORGAN STANLEY | 21,000 | $29,000 | 0.00% |
ACADIAN ASSET MANAGEMENT LLC | 7,229 | $10,000 | 0.00% |
Citadel Advisors | 26,568 | $38,000 | 0.00% |
Renaissance Technologies | 71,533 | $102,000 | 0.00% |
Hilton Capital Management, LLC | 667 | $1,000 | 0.00% |
VANGUARD GROUP INC | 110,976 | $158,000 | 0.00% |